KRAS and neoplasm: Predictive biomarkers in colorectal carcinoma, such as mismatch repair (MMR) status and the mutational tumor profile—including BRAF, KRAS, NRAS, TP53, PIK3CA, and other mutations—carry biological and therapeutic significance.